However, it should be noted that since FLT3-ITD mutation was present at a much lower frequency in CBF-AML (4.7% in our study and 7% in literature) than in intermediate-risk AML [51], the interaction between high IL2RA expression and FLT3-ITD mutation should be rather limited. This evidence concerns the gene FLT3 and acute myeloid leukemia.